NP
NorthRock Partners Portfolio holdings
AUM
$3.86B
1-Year Return
13.95%
This Quarter Return
+9.72%
1 Year Return
+13.95%
3 Year Return
+63.93%
5 Year Return
+112.1%
10 Year Return
+187.97%
AUM
$1.33B
AUM Growth
+$114M
(+9.4%)
Cap. Flow
+$26.7M
Cap. Flow
% of AUM
2%
Top 10 Holdings %
Top 10 Hldgs %
64.96%
Holding
365
New
85
Increased
169
Reduced
62
Closed
27
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$5.54M |
| 2 |
Apple
AAPL
|
$2.93M |
| 3 |
Microsoft
MSFT
|
$2.1M |
| 4 |
SPDR Portfolio S&P 500 Value ETF
SPYV
|
$2.03M |
| 5 |
PepsiCo
PEP
|
$1.37M |
Top Sells
| 1 |
TNFA
TNF Pharmaceuticals, Inc. Common Stock
TNFA
|
$9.75M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
$7.75M |
| 3 |
Target
TGT
|
$6.37M |
| 4 |
Ameriprise Financial
AMP
|
$4.22M |
| 5 |
IBM
IBM
|
$1.61M |
Sector Composition
| 1 | Consumer Staples | 10.8% |
| 2 | Technology | 9.43% |
| 3 | Financials | 3.71% |
| 4 | Healthcare | 3.68% |
| 5 | Consumer Discretionary | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Emerson Electric
EMR
$74.6B
| $225K | 0.02% |
2,421
+73
| +3% | +$6.78K |
|
302
HP
HPQ
$27.4B
| $224K | 0.02% |
+5,935
| New | +$224K |
|
303
Sherwin-Williams
SHW
$92.9B
| $224K | 0.02% |
+637
| New | +$224K |
|
304
Valero Energy
VLO
$48.7B
| $223K | 0.02% |
+2,967
| New | +$223K |
|
305
Parker-Hannifin
PH
$96.1B
| $221K | 0.02% |
+696
| New | +$221K |
|
306
lululemon athletica
LULU
$19.9B
| $220K | 0.02% |
+561
| New | +$220K |
|
307
Vanguard High Dividend Yield ETF
VYM
$64.2B
| $219K | 0.02% |
1,952
+34
| +2% | +$3.82K |
|
308
Vericel Corp
VCEL
$1.72B
| $216K | 0.02% |
5,495
+21
| +0.4% | +$825 |
|
309
Fidelity National Information Services
FIS
$35.9B
| $213K | 0.02% |
+1,953
| New | +$213K |
|
310
Vanguard Value ETF
VTV
$143B
| $212K | 0.02% |
+1,441
| New | +$212K |
|
311
KeyCorp
KEY
$20.8B
| $211K | 0.02% |
+9,111
| New | +$211K |
|
312
Synopsys
SNPS
$111B
| $208K | 0.02% |
+564
| New | +$208K |
|
313
MGM Resorts International
MGM
$9.98B
| $207K | 0.02% |
+4,616
| New | +$207K |
|
314
Capital One
COF
$142B
| $206K | 0.02% |
+1,421
| New | +$206K |
|
315
Boston Scientific
BSX
$159B
| $204K | 0.02% |
+4,795
| New | +$204K |
|
316
ResMed
RMD
$40.6B
| $204K | 0.02% |
783
+15
| +2% | +$3.91K |
|
317
Chubb
CB
$111B
| $202K | 0.02% |
+1,044
| New | +$202K |
|
318
Gilead Sciences
GILD
$143B
| $201K | 0.02% |
2,768
-3,554
| -56% | -$258K |
|
319
DuPont de Nemours
DD
$32.6B
| $200K | 0.02% |
2,474
-10,014
| -80% | -$810K |
|
320
Cohen & Steers Infrastructure Fund
UTF
$2.53B
| $200K | 0.02% |
+7,010
| New | +$200K |
|
|
WRK
321
DELISTED
WestRock Company
WRK
| $200K | 0.02% |
+4,502
| New | +$200K |
|
|
PXD
322
DELISTED
Pioneer Natural Resource Co.
PXD
| $200K | 0.02% |
+1,101
| New | +$200K |
|
323
Lumen
LUMN
$4.87B
| $152K | 0.01% |
12,074
-559
| -4% | -$7.04K |
|
|
SRNE
324
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $116K | 0.01% |
+25,000
| New | +$116K |
|
325
Glimpse Group
VRAR
$29.3M
| $99K | 0.01% |
+10,061
| New | +$99K |
|